Board of Directors
Ophthalmic Orphan Programs
Gene Therapy Research
Committed to discovering and developing novel therapeutics and gene therapy solutions to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases
Ophthotech Reports First Quarter 2018 Financial and Operating Results
May 9th, 2018 07:00:00 AM
Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura® in Combination with Anti-VEGF Therapy in Wet Age-Related Macular Degeneration
May 1st, 2018 07:35:00 AM
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases.
View Our Latest Corporate Presentation
Dr. Kourous Rezaei, Senior Vice President and Chief Medical Officer at Ophthotech. "Image en Ophtalmologie" a publication of Edimark.